Dimensional Fund Advisors LP Has $11.71 Million Holdings in Embecta Corp. (NASDAQ:EMBC)

Dimensional Fund Advisors LP boosted its stake in shares of Embecta Corp. (NASDAQ:EMBC) by 14.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 566,993 shares of the company’s stock after buying an additional 73,165 shares during the period. Dimensional Fund Advisors LP’s holdings in Embecta were worth $11,708,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in EMBC. William Blair Investment Management LLC acquired a new stake in shares of Embecta in the fourth quarter valued at approximately $15,270,000. Raymond James Financial Inc. bought a new stake in Embecta during the 4th quarter worth about $6,598,000. American Century Companies Inc. boosted its stake in shares of Embecta by 8.0% during the 4th quarter. American Century Companies Inc. now owns 3,261,934 shares of the company’s stock worth $67,359,000 after buying an additional 242,668 shares during the last quarter. Brandywine Global Investment Management LLC bought a new position in shares of Embecta in the 4th quarter valued at about $4,043,000. Finally, JPMorgan Chase & Co. raised its stake in shares of Embecta by 121.1% during the 4th quarter. JPMorgan Chase & Co. now owns 321,126 shares of the company’s stock worth $6,631,000 after purchasing an additional 175,857 shares in the last quarter. Institutional investors own 93.83% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Mizuho began coverage on Embecta in a research note on Thursday, April 10th. They issued a “neutral” rating and a $15.00 price objective on the stock.

Embecta Trading Down 9.8 %

Shares of Embecta stock opened at $12.00 on Friday. The company has a market cap of $697.61 million, a PE ratio of 12.00, a price-to-earnings-growth ratio of 0.78 and a beta of 1.24. The company has a 50 day moving average of $12.46 and a 200-day moving average of $15.75. Embecta Corp. has a 1-year low of $10.83 and a 1-year high of $21.48.

Embecta (NASDAQ:EMBC) last announced its quarterly earnings results on Friday, May 9th. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. Embecta had a net margin of 5.25% and a negative return on equity of 19.22%. The company had revenue of $259.00 million for the quarter, compared to analyst estimates of $261.77 million. During the same period in the previous year, the firm posted $0.67 EPS. The firm’s revenue was down 9.8% on a year-over-year basis. Research analysts forecast that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Wednesday, May 28th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 5.00%. Embecta’s dividend payout ratio (DPR) is currently 60.00%.

Insider Buying and Selling at Embecta

In other Embecta news, Director Milton Mayo Morris sold 3,100 shares of the business’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $16.38, for a total transaction of $50,778.00. Following the completion of the sale, the director now directly owns 36,133 shares of the company’s stock, valued at approximately $591,858.54. The trade was a 7.90 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.42% of the company’s stock.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.